Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Great. Good afternoon, everyone. My name is Jess Fye. I'm one of the biotech analysts at JPMorgan. And we're continuing the 2020 Healthcare Conference today with Crinetics. We are going to do a Q&A session with the management team right after this, just down the hall in the Sussex Room. And for the presentation, let me turn it over to the company's CEO, Scott Struthers.
Thanks, Jess, and thanks for the invite. Hello, everybody. Thanks for coming today. I'd like to tell you a bit of an update about the company. There's a pretty data-rich website -- deck on our website, so I'd encourage you to go there if you want to see more details, but I'll kind of skip through some of the highlights here today. And I think the thing to know about us at Crinetics is we're really trying to build something special that can bring new drugs to patients around the world in the area of endocrinology and endocrine
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |